Insulin resistance is a common but often underrecognized contributor to weight gain, fatigue, metabolic dysfunction, and long-term cardiometabolic risk. Many individuals develop insulin resistance gradually, even when standard blood sugar tests appear “normal.”
This page explains what insulin resistance is, why it matters clinically, and how LiteWell evaluates and addresses insulin resistance using a physician-led, data-driven approach.
Satisfied with our services
Insulin resistance occurs when the body’s cells become less responsive to insulin, the hormone responsible for regulating blood glucose. As a result, the body compensates by producing higher levels of insulin to maintain normal blood sugar levels.
Over time, this process can contribute to weight gain, energy fluctuations, abnormal lipid levels, inflammation, and increased risk for conditions such as type 2 diabetes and cardiovascular disease.
Many patients are told their labs are “normal” because fasting glucose or hemoglobin A1c values fall within reference ranges. However, insulin resistance may be present years before these markers become abnormal.
Early insulin resistance is often associated with elevated fasting insulin levels, unfavorable triglyceride-to-HDL ratios, central weight gain, and post-meal energy crashes.
LiteWell evaluates insulin resistance through a comprehensive clinical process that integrates laboratory testing, symptom assessment, and physician interpretation.
Most patients begin with a Free Medical Fit Call, followed by the Premier Discovery Intake when appropriate. This intake provides the clinical data needed to assess metabolic health in context.
– Fasting insulin levels
– Fasting glucose and hemoglobin A1c
– Triglyceride-to-HDL cholesterol ratio
– Comprehensive lipid panel
– Inflammatory markers such as hs-CRP
– Additional metabolic markers when clinically indicated
LiteWell offers physician-led services designed to evaluate and address underlying contributors to insulin resistance as part of a structured, individualized care pathway.
For appropriate patients, LiteWell develops personalized strategies to improve insulin sensitivity and overall metabolic health. Care plans may include nutritional strategies, activity guidance, medication-based interventions, and ongoing monitoring.
All treatment decisions are individualized, physician-supervised, and guided by objective clinical data.
No. Insulin resistance can exist for years before diabetes develops. Early identification allows for intervention before progression.
Yes. Many individuals have normal glucose and A1c levels while fasting insulin and other markers indicate insulin resistance.
Insulin resistance can contribute to fat storage, particularly around the abdomen, and make weight loss more difficult.
In many cases, insulin sensitivity can be improved with appropriate medical and lifestyle interventions, though responses vary by individual.
When clinically appropriate, physician-supervised medications may be considered as part of a comprehensive care plan.
LiteWell services are offered on a direct-pay basis and are not typically billed through insurance.
Most patients begin with a Free Medical Fit Call, followed by the Premier Discovery Intake if appropriate.
If insulin resistance is suspected, early medical evaluation may help clarify contributing factors and guide next steps. LiteWell offers a structured, physician-led approach focused on metabolic health optimization.
